Explore how a patient’s health care journey can be improved through the utilization of PGx testing along with CMM service delivery in a Medicare population. Supporting this, are two peer-reviewed use cases on the economic implications in an elderly population and five key proof points and success factors for PGx + CMM in terms of cost saving and utility.
Developed by the Pharmacogenomics Payment and Policy Taskforce.